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ABSTRACT: We describe de novo designed -helical barrels (HBs) that bind and discriminate between lipophilic biologically 
active molecules.  HBs have five or more α helices arranged around central hydrophobic channels the diameters of which scale with 
oligomer state.  We show that pentameric, hexameric and heptameric HBs bind the environmentally sensitive dye, 1,6-diphenyl-
hexatriene (DPH) in the M range and fluoresce.  Displacement of the dye is used to report the binding of non-fluorescent molecules: 
palmitic acid and retinol bind to all three HBs with sub-M inhibitor constants; farnesol binds the hexamer and heptamer; but -
carotene only binds to the heptamer.  A co-crystal structure of the hexamer with farnesol reveals oriented binding in the centre of the 
hydrophobic channel.  Charged side chains engineered into the lumen of the heptamer facilitate binding of polar ligands: a glutamate 
variant binds a cationic variant of DPH; and introducing lysine allows binding of the biosynthetically important farnesol diphosphate. 
INTRODUCTION 
  Protein design has advanced sufficiently that it is now possible 
to generate successfully a variety of stable protein structures 
from first principles.1-2  This can be done using rules of thumb 
that relate protein sequence to structure or by employing com-
putational methods.3-5  New challenges for this field of de novo 
protein design include: (1) taking forays into the so-called dark 
matter of protein space, i.e., designing entirely new protein 
structures not observed in nature;6-7 (2) making the design meth-
ods open and accessible to others, particularly to non-specialist 
users;8 and (3) building on these scaffolds and methods to de-
liver functional de novo proteins.9-10  Desired functions include 
biomolecular recognition and sensing, and catalysis or enzyme-
like activities.11-12  A requirement for many such functions is 
that the designed protein scaffolds bind and discriminate be-
tween various molecules, e.g., bioactive small molecules and 
biological macromolecules. 
  In biological systems, protein-ligand dissociation constants 
range from mM to fM.13  Moreover, many receptors respond to 
multiple ligands across a range of binding affinities. One ad-
vantage of the one receptor-multiple ligand model is that it re-
moves the need to synthesize a specific receptor for every pos-
sible protein-ligand interaction.  The olfactory network pro-
vides a natural example of such a system.14 In humans, genes 
encoding circa 400 G-protein coupled receptors are able to dis-
tinguish up to 1 trillion different stimuli through low affinity 
and relatively non-selective recognition of odorants.15 
  The design and engineering of new proteins that recognize and 
bind peptides and folded proteins has achieved considerable 
success, particularly using directed evolution to modify either 
natural protein folds or de novo scaffolds generated by consen-
sus design.4, 12  However, the recognition and binding of small 
molecules has proven more challenging.16-18  Two related issues 
here are the generation of scaffolds that act as good receptors 
for small molecules, and then the embellishment of these to dis-
criminate between what are often very similar molecules.  The 
small sizes and limited functional groups of the target molecules 
often confound attempts to recognize, bind and distinguish 
them.  One solution is to adapt natural proteins with cavities 
already evolved to bind small-molecule ligands.19-20  Here, we 
add de novo proteins with central accessible channels to this 
repertoire of small-molecule-binding proteins.  These can be 
adapted for the recognition, binding and release of ligands. 
  Our designs are based on de novo -helical coiled coils.  The 
vast majority of coiled coils are bundles with 2 – 4 helices 
wrapped around a central superhelical axis leading to solid hy-
drophobic cores.21  These structures are directed by underlying 
sequence repeats of hydrophobic (h) and polar (p) residues, 
hpphppp, often denoted abcdefg.  The 3,4-hydrophobic repeats 
drive the folding of amphipathic  helices, which assemble into 
bundles to bury their hydrophobic, a+d faces.  The helices 
supercoil around each other because the 3.5-residue sequence 
repeat and the 3.6-residue structural repeat do not match pre-
cisely.  These relatively straightforward structural principles, 
and the sequence-to-structure relationships that have followed, 
have made coiled coils attractive targets for protein design.3  
This has resulted in myriad de novo coiled-coil homo-dimers, 
trimers and tetramers and reliable sets of de novo hetero-dimeric 
and trimeric systems.22  
  Apart from a small number of examples,23-24 however, these 
traditional coiled-coil dimers – tetramers do not have suitable 
internal cavities or central channels to provide a basis for ligand 
  
Figure 1. Structures of the coiled-coil assemblies and small molecules investigated herein.  (A) Orthogonal views of the space-filled models 
(top) and ribbon diagrams (bottom) of the X-ray structures of CC-Tri (orange; PDB code 4dzl), CC-Tet (green; PDB code 3r4a), CC-Pent 
(blue; PDB code 4pn8), CC-Hex2 (purple; PDB code 4pn9), and CC-Hept (red; PDB code 4pna). (B) Hydrophobic molecules tested for 
encapsulation into the hydrophobic channels of the de novo designed αHBs: 1, DPH; 2, Prodan; 3, TMA-DPH; 4, palmitic acid; 5, retinol; 
6, farnesol; 7, β-carotene; 8, farnesyl diphosphate (FPP). 
 
binding.  To make coiled coil-based receptors for small mole-
cules requires oligomer states of five and above, because these 
are -helical barrels (HBs) with central, accessible channels.25  
Generally, these have sequence patterns that expand the tradi-
tional heptad repeat, e.g. hpphhph and others.26  Both natural 
and engineered HBs are known but they are rare.27  For exam-
ple, the oligomerization domain of cartilage oligomeric matrix 
protein (COMPcc), a pentamer with a 7 Å diameter central 
channel, sequesters hydrophobic molecules such as fatty acids, 
vitamins and cholesterol.27-29   Turning to engineered and de-
signed proteins: the pentameric Trp-zipper has a cavity that 
binds polyethylene glycol;30 the serendipitously discovered 
hexamer, CC-Hex,31 binds a small-molecule dye;32 and a mu-
tant of the GCN4 leucine zipper peptide, GCN4-pAA, forms a 
heptameric spiral of helices33 with a central cavity that also 
binds hydrophobic dyes.34  There are other examples of coiled-
coil oligomers above pentamer but, to our knowledge, these ei-
ther do not have central channels or their binding/transport 
properties have not been fully characterised.35-37  Indeed, adding 
specificity of binding for small molecules has not been ad-
dressed formally by any of the above reports.  
  The coiled coil is a parameterizable protein fold;38 i.e., there 
are equations that allow coiled-coil structures to be built ab in-
itio making them accessible to computational design.25, 39-44  We 
have combined parametric design and the use of hpphhph-type 
sequences to deliver a set of de novo HBs from pentamer to 
heptamer and characterized these through to X-ray protein crys-
tal structures.25  These highly stable assemblies have melting 
temperatures above 95 °C,25 and, by analogy to de novo coiled-
coil dimers – tetramers, we estimate the dissociation constants 
of the HBs to be in the sub-nM regime.22, 45  Furthermore, 
these HBs are robust to mutation allowing the engineering of 
coiled coil-based nanotubes,32, 46 and the generation of variants 
with engineered lumens that perform rudimentary catalysis.9  
  Here we describe how these computationally designed HBs 
can be adapted to render de novo protein receptors that bind and 
discriminate between a panel of biologically important lipo-
philic small molecules.  The internal shape and diameter of the 
HBs, which ranges from ≈ 5 – 7 Å, provides a first level of 
discrimination: the different barrels bind different targets with 
a range of affinities from sub-µM upwards.  Further discrimi-
nation is achieved by adding charged side chains to the lumens 
to direct the binding of lipophilic molecules with formally 
charged headgroups.  We combine experimental spectroscopic 
and high-resolution structural studies with molecular modelling 
and dynamics simulations to provide insight into the modes of 
binding and how these systems might be engineered for appli-
cations in biotechnology and synthetic biology. 
 
RESULTS and DISCUSSION 
  Different αHBs have binding abilities.  We chose three 
HBs from the available computationally design structures,25 
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Table 1. Dissociation constants and inhibition constants of small molecules binding to the HBs.  
 CC-Pent CC-Hex2 CC-Hept 
KD [μM] KI [μM] KD [μM] KI [μM] KD [μM] KI [μM] 
DPH (1) 4.5 ± 0.9 - 1.6 ± 0.2 - 1.3 ± 0.3 - 
Prodan (2) 401 ± 14 - 6.5 ± 1.1 - 5.8 ± 0.6 - 
TMA-DPH (3) 15.5 ± 0.9 - 14.8 ± 1.4 - 13.3 ± 1.3 - 
Palmitic acid (4) - 0.8 ± 0.3 - 0.7 ± 0.2 - 0.5 ± 0.2 
Retinol (5) - 10.2 ± 2.8 - 2.9 ± 1.3 - 2.5 ± 0.4 
Farnesol (6) - 23.9 ± 2.4 - 0.6 ± 0.2 - 0.4 ± 0.1 
β-Carotene (7) - nd1 - 74  ± 27 - 5.9 ± 3.0 
1A KI could not be determined because of weak binding of β-carotene to CC-Pent. 
 
namely CC-Pent, CC-Hex2, and CC-Hept (Fig 1A).  The se-
quences of these hyperstable assemblies are similar (Table S2, 
Supplementary Fig 1), and the Ile/Leu-lined channels differ 
only in diameter, which increases through the series CC-Pent to 
CC-Hept.25  To quantify this, the three X-ray crystal structures 
were analyzed by Pore Walker (Supplementary Fig 2 and Sup-
plementary Table 3),47 which revealed variations in the diame-
ters of the channels in CC-Pent, CC-Hex2 and CC-Hept of 3.0 
Å – 7.4 Å, 4.7 Å – 7.7 Å, and 5.4 Å - 10.1 Å, respectively. 
  Channels of similar chemistry and dimensions bind hydropho-
bic dyes, including the rod-shaped 1,6-diphenylhexatriene 
(DPH; 1, Fig 1B) and the more sterically demanding Prodan (2, 
Fig 1B).32, 34, 46, 48  We reasoned that differences in channel di-
ameter between CC-Pent, CC-Hex2 and CC-Hept should dif-
ferentiate binding of the same molecule, which could lead to 
specific binding of particular hydrophobic molecules or molec-
ular classes (Fig 1B).  To explore this in silico, we built models 
with the dyes docked into the channels of the X-ray crystal 
structures of the three HBs and minimized the energy of the 
complexes in Gromacs (Supplementary Fig 3).  All three barrels 
accommodated DPH, whereas Prodan only fitted into the chan-
nels of CC-Hex2 and CC-Hept. 
  We used fluorescence spectroscopy to probe binding of the 
two dyes to the HBs (Fig 2) as the fluorescence of both dyes 
is environmentally sensitive:49-50  DPH only fluoresces (λmax 
455 nm) when in hydrophobic environments; and the emission 
fluorescence spectrum of Prodan is enhanced and blue-shifted 
(from 520 nm to 424 nm) when transferred to apolar surround-
ings.  As negative controls for any background binding, we used 
a de novo coiled-coil trimer (CC-Tri) and a de novo tetramer 
(CC-Tet), which do not have channels or pores (Fig 1A).22  Nei-
ther of the dyes fluoresced with either control over peptide con-
centrations of 10 M – 300 M (Figs 2A-D).  By contrast, 50 
M concentrations of all three HBs fluoresced with 1 M 
DPH (Fig 2A).  Prodan bound to CC-Hex2 and CC-Hept, but 
not to the smaller CC-Pent (Fig 2B). 
  Binding was quantified by titrating increasing amounts of the 
αHB peptides into fixed, 1 M concentrations of DPH or 
Prodan (Figs 2C-D).  The resulting saturation-binding curves 
fitted to single-site binding models to return dissociation con-
stants (KD; Table 1): all three HBs bound the rod-shaped DPH 
with low µM KDs; Prodan bound similarly to CC-Hex2 and CC-
Hept, but weakly to CC-Pent. 
  In addition, sedimentation velocity analytical ultracentrifuga-
tion experiments for CC-Pent, CC-Hex2 and CC-Hept in the 
presence of DPH could be followed directly by monitoring the 
absorbance of DPH at 350 nm. Thus, the peptides and dye co-
sediment indicating that the two are bound together, which we 
interpret as the dye being encapsulated by the HBs. Moreover, 
analysis of the sedimentation data confirmed that the oligo-
meric states of the assemblies were unaffected by the presence 
of the small molecule (Supplementary Fig 4).   
  HB receptors induce chirality in the encapsulated dyes.  
DPH and Prodan are flat, achiral molecules.  Nonetheless, we 
reasoned that the chiral environment of the protein channels 
might induce a circular dichroism (CD) effect.51  In free solu-
tion, although both molecules absorbed strongly in the near-UV 
neither had associated CD spectra (Figs 2E&F).  However, 
when bound to DPH all three HBs showed strong CD bands 
centered on ≈350 nm with vibrational fine structure (Fig 2E).  
Interestingly, these data showed a clear inverse correlation with 
HBs pore size: the intensity of the CD signal decreased 
through the series CC-Pent to CC-Hex2 to CC-Hept (Fig 2E).  
However, CD spectra were only observed for Prodan with CC-
Hex2 and CC-Hept (Fig 2F) consistent with the binding data 
from fluorescence spectroscopy. 
  Computational modelling sheds light on the modes of DPH 
binding to HBs.  MD simulations can identify binding sites 
and binding modes of small molecules in natural52 and de novo 
proteins.53  DPH was docked into the channels of the X-ray 
crystal structures for the three HBs using AutoDock Vina (Fig 
3A, Supplementary Fig 5A-C).54  Three binding sites for each 
HB were found: site 1, near the C terminus; a central site 2; 
and site 3 near the N terminus.  Each site consists of two wid-
ened voids separated by a narrow section formed by the ring of 
Leu residues at the a position; and adjacent sites share a void 
(Supplementary Fig 5D).  For each identified binding pose, the 
bulky phenyl rings are accommodated in the cavities whereas 
the thinner hexatriene moiety fits in the narrowed sections.  For 
CC-Hept, the different poses were found to have similar bind-
ing scores (≤ 0.5 kcal/mol, as calculated by the Autodock vina 
scoring function), irrespective of the position of DPH in binding 
site 1, 2 or 3 (Supplementary Table 4).  For CC-Hex2, similar 
scores were obtained for DPH in sites 1 and 2, but site 3 was 
predicted to be less favorable.  For CC-Pent the three sites had 
markedly different binding scores with site 1 predicted to be the 
most favorable binding site followed by site 2 and then site 3.  
The lower score for site 3 can be rationalized as it is too small 
to fully accommodate the phenyl moiety of DPH, leaving it par-
tially solvent exposed.  
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Figure 2. Fluorescence and CD spectroscopy of DPH (left) and 
Prodan (right) binding to HBs. Emission fluorescence spectra 
for DPH (A) and Prodan (B) with coiled-coil peptides. Saturation 
binding curves of the peptides to DPH (C), and to Prodan (D).  
CD spectra of dye in the absence (black dotted line) and presence 
of HBs (solid lines) for DPH (E), and Prodan (F), and of αHBs 
without dye (colored dotted lines).  Color key: CC-Tri (orange), 
CC-Tet (green), CC-Pent (blue), CC-Hex2 (purple), CC-Hept 
(red).  Conditions: (A&B) 50 M peptide, 1 M dye, HEPES 
buffered saline (HBS; 25 mM HEPES, 100 mM NaCl, pH 7.0), 
5% v/v DMSO; (C&D) 1.4 M – 100 M of the coiled-coil as-
sembly, 1 M dye, HBS, 5% v/v DMSO; (E) 200 M peptide, 
5 M DPH, HBS, 5% v/v DMSO; and (F) 200 M peptide, 
20 M Prodan, HBS, 5% v/v DMSO. 
 
  To confirm that the binding sites identified were favorable and 
the docking poses stable, extensive molecular dynamics (MD) 
simulations were initiated starting from 5 poses for each site 
and running 200 ns of simulation per pose, leading to a total of 
1 s of simulation for each binding site.  These indicated that 
ligand binding to each site was stable (Fig 3B-D, Supplemen-
tary Figs 6 & 7 and Supplementary Movie 1).  For CC-Pent and 
CC-Hept the overall protein structures did not change signifi-
cantly from the X-ray crystal structures with or without DPH.  
This was quantified by backbone root mean square deviations 
(RMSDs) through the trajectories (Supplementary Fig 8), 
which reached maxima ≤ 2 Å in both cases.  By contrast, the 
average RMSDs for CC-Hex2 for both the apo and DPH-bound 
forms were >3 Å, suggesting that the solution-phase structure 
might deviate from the crystal structure.  We attribute this to a 
change in superhelix of CC-Hex2, which relaxed to a higher 
pitch over the MD trajectories (Supplementary Fig 9) leading 
to a longer, narrower channel of diameter 3 Å –  6 Å calculated 
by HOLE (Supplementary Fig 10).55  A similar analysis for CC-
Pent revealed that the presence of DPH lead to an expansion of  
the channel around each binding site to accommodate the ligand 
when compared with the apo simulations.  This is especially 
marked in the narrowed sections where the diameter of the 
channel increase by up to 1.5 Å.  In addition, this expansion to 
accommodate DPH increases the overall curvature of the heli-
ces in the central region of the barrel (Supplementary Fig 9).  In 
contrast, CC-Hex2 and CC-Hept showed a subtle tightening in 
response to the ligand (Supplementary Fig 10).  Presumably, 
this improves van der Waals’ contacts between protein and lig-
and.   
  Turning to the dynamics of the DPH molecule (Figs 3B-D, 
supplementary Figs 6 & 11):  at site 1 of CC-Pent, CC-Hex2 
and CC-Hept DPH was stable in its starting binding position; 
whereas, at sites 2 and 3 of CC-Hept we observed DPH moving 
between these sites in several trajectories.  This suggests a rel-
atively low energy barrier between these two sites of CC-Hept 
compared to the barrier between site 1 and 2, and between any 
adjacent sites in CC-Pent and CC-Hex2.  Moreover, the central 
site 2 was preferred over site 3 in these transitions in CC-Hept 
indicating a lower binding energy of DPH in site 2.  Detailed 
analysis of these events showed that the transition itself was fast 
(between 10 and 20 ps) and did not noticeably perturb the pro-
tein structure (Supplementary Fig 12).  The preferred positions  
 
 
Figure 3. Docking and molecular dynamics simulations of DPH 
bound to CC-Pent (blue) and CC-Hept (red). (A) Binding poses of 
DPH obtained from docking for each identified binding site (5 
poses per site). Superpositions of snapshots from the ensuing MD 
simulations starting with DPH docked in site 1 (B), site 2 (C) and 
site 3 (D) of each HB. The snapshots (fine ribbons and sticks) are 
for every 10 ns of 1 s trajectories. The thick ribbons and sticks 
correspond to a representative conformation of each of the trajec-
tories. The proteins are oriented with the C termini of the peptides 
on the right. 
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for the phenyl groups were the widened voids, even for CC-
Hept that has a larger channel than the other HBs.  This sug-
gests that less-sterically-demanding linear chains are better ac-
commodated in the narrowed sections of the channels, whereas 
bulkier groups reside more favorably in the wider voids, adding 
a new level of selection to the binding modes of small mole-
cules inside HBs. 
  For CC-Hept, the ligand also moved in the plane orthogonal 
to the long-axis of the channel axis and rotated freely, presum-
ably due to the larger diameter of its channel (Supplementary 
Figs 13 & 14).  Consistent with the tighter channels, these mo-
tions were restricted for CC-Pent and CC-Hex2, and changes in 
ligand position or orientation were discrete, infrequent events, 
especially in the case of CC-Hex2 site 2 and CC-Pent site 2 and 
3.  Together, these simulations reveal increased restrictions in 
ligand binding and movement as channel diameter shrinks in 
the series CC-Hept, CC-Hex2, CC-Pent.  It is interesting that 
this correlates with in the increased intensity of induced CD sig-
nal of DPH. 
  HB bind biological lipophilic molecules.  To explore if 
HBs are able to sequester other rod-shaped, lipophilic mole-
cules, we tested the binding of palmitic acid (4), and the terpe-
noids retinol (5), farnesol (6) and -carotene (7) (Fig 1).  Pal-
mitic acid plays roles in the synthesis and regulation of fatty 
acids, and is a common post-translational modification serving 
as a membrane anchor for protein trafficking.56-57  The retinoids, 
retinol and retinoic acid, are involved in regulatory processes, 
including epithelial cell growth and cellular differentiation, and 
retinal (vitamin A) is found in the opsin protein class, e.g. rho-
dopsin.58-59  Retinal cannot be synthesized by humans and is 
taken up as a retinylester or the provitamin -carotene (7), 
which is cleaved enzymatically to give two retinal molecules.60-
61  Farnesol has anti-fungal properties and anti-tumor and chem-
opreventative effects in animal models, which is mainly due to 
it inhibiting cell growth and proliferation and inducing apopto-
sis.62-63 
  The binding propensities of these molecules to the HBs were 
determined from a displacement assay as follows.  In place of 
DPH, the more-water-soluble trimethylammonium-DPH 
(TMA-DPH; 3, Fig 1) was used as the fluorescent reporter.  
This bound all three HBs with KDs of 13 M - 16 M (Table 
1 and Supplementary Fig 15 & Table 5).  HBs were equili-
brated for 2 hours with TMA-DPH in approximately 25-fold 
excess at 20 °C and titrated with the analytes 4 – 7.  Decreases 
in fluorescence with increased analyte concentration were fitted 
to a one-site competition model to obtain IC50 values, which 
were converted to the inhibition constants (KI; Equation S3). 
  There was a clear trend in the data across the panel of analytes 
(Fig 4A, Table 1).  The most flexible n-alkyl chain of palmitic 
acid (4) was sequestered equally by all three HBs with sub-
M KI values.  In contrast, HBs bound the unsaturated ligands 
differentially as follows.  Retinol was bound by CC-Hex2 and 
CC-Hept with KI ≈ 3 M, but binding to CC-Pent was three 
times poorer (Fig 4B).  The HBs discriminated farnesol with 
sub-M inhibition constants to CC-Hept and CC-Hex2, respec-
tively, but no appreciable binding to CC-Pent (Fig 4C).  Finally, 
for the largest ligand, -carotene (7), only binding to CC-Hept 
could be quantitated (Table 1, Fig 4D). 
  We offer the following explanation for the differences in bind-
ing of the three terpenoids.  First, compared with palmitic acid, 
which is not discriminated by the HBs at all, the partially un-
saturated and methylated chain of farnesol results in selectivity 
of binding for the larger barrels (CC-Hex2 and CC-Hept) and 
against CC-Pent.  Second, the bulky cyclohexene group that ter-
minates retinol lowers the binding efficiency to all HBs.  
Third, the two cyclohexene head groups of β-carotene inhibit 
binding to the two smaller barrels (CC-Pent and CC-Hex2). 
 
 
Figure 4. Binding of various lipophilic biomolecules to HBs.  
Fluorescence-based displacement assays using TMA-DPH as the 
reporter in complex with CC-Pent (blue), CC-Hex2 (purple) or CC-
Hept (red), and titrated against palmitic acid (4, A), retinol (5, B), 
farnesol (6, C), and β-carotene (7, D).  (E) 1.85 Å X-ray crystal 
structure of farnesol bound in the channel of CC-Hex2 (PDB: 
6EIZ). Electron density 2F0-Fcalc for the ligand is shown at 1.4 .  
Conditions for A - C: 50 M TMA-DPH, 1.4 - 2 M coiled-coil 
assembly, HBS, 5% v/v DMSO, 20 ˚C, concentration of ligands 
varied between 0.1 and 500 M. D: As A – C with addition of 4% 
THF. 
 
  A CC-Hex2: farnesol complex elucidated by X-ray crystal-
lography.  To define the binding in atomic detail, we screened 
crystal soaks and found that CC-Hex2 co-crystallized with far-
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nesol.  A 1.85 Å resolution X-ray crystal structure for the com-
plex was solved by molecular replacement using apo-CC-Hex2 
(PDB code 4pn9)25 as the search model (Supplementary Table 
6, Fig 4E, and Supplementary Fig 16).  This confirmed the sin-
gle-molecule binding mode assumed above, and revealed far-
nesol bound approximately in the middle of the channel.  More-
over, and in contrast to the many other X-ray crystal structures 
and MD simulations of HBs that we have solved and per-
formed, there was density consistent with ordered hydrogen-
bonded water molecules connecting the hydroxyl functionality 
of farnesol to bulk solvent (Fig 4E). 
  The lumens of HBs can be engineered to accept charged 
molecules.  Hydrophilic and charged side chains can be intro-
duced into the otherwise exclusively hydrophobic lumens of de 
novo HBs without major structural changes.9, 31  For instance, 
a robustly folded CC-Hept variant with three mutations per 
chain, CC-Hept-Cys-His-Glu, has been designed and shows ru-
dimentary catalytic activity in ester hydrolysis.9 We reasoned 
that ionizable residues could be included to help sequester 
charged analytes into the channels.  To test this, we chose the 
larger scaffold, CC-Hept as it should tolerate charged side 
chains and be receptive to larger, more-complex molecules.  
Specifically, we introduced lysine and glutamate residues to 
bind anions and cations, respectively. We modified positions 
Ile-17 and Ile-24 and found that Ile-24 of CC-Hept was the most 
robust towards substitution for Lys or Glu—to give CC-Hept-
I24K and CCHept-I24E—without compromising the structure 
or stability of the HB (Supplementary Table 2, and Supple-
mentary Figs 17-22).  We obtained an X-ray crystal structure 
for the latter (Supplementary Fig 17). 
  Binding experiments with cationic TMA-DPH demonstrated 
that the two variants discriminated this ligand as expected: the 
ligand was relatively weakly bound by both CC-Hept and CC-
Hept-I24K (KD’s of 13.3 ± 1.3 M and 12.8 ± 0.6 M, respec-
tively, Fig 5A); whereas, binding to CC-Hept-I24E was almost 
an order of magnitude tighter at 1.6 ± 0.1 M (Fig 5A, purple 
trace).  Using the TMA-DPH displacement assay, CC-Hept-
I24K and CC-Hept-I24E accommodated neutral farnesol with 
KIs of 1.8 ± 0.3 M and 1.0 ± 0.04 M, respectively (Fig 5B). 
  Finally, we tested the binding of the anionic and biologically 
important farnesyl diphosphate (8, FPP).  FPP is the precursor 
of sesquiterpenoids, including the antimalarial drug artemisinin 
and squalene the precursor of sterols;64 and it is a substrate of 
protein prenyltransferases involved in trafficking of proteins to 
membranes.65  Using the displacement assay, we found that the 
exclusively hydrophobic channel of CC-Hept and the nega-
tively charged channel of CC-Hept-I24E bound FPP only 
weakly (Fig 5C).  By contrast, FPP bound to CC-Hept-I24K 
greater than ten times tighter with a measurable KI of 1.5 ± 
0.2M (Fig 5C). 
  These data for FPP are most probably explained by binding 
being driven by its hydrophobic tail displacing TMA-DPH from 
the channels of CC-Hept and CC-Hept-I24E, and leaving the 
charged diphosphate headgroup outside of the channel.  With 
CC-Hept-I24K the latter could also be accommodated within 
the channel by the positively charged hepta-lysine.  We probed 
this in silico by docking charged FPP in the channel of a model 
for CC-Hept-I24K.  Three binding poses were selected and a 
100 ns constant-pH MD (CpHMD) simulation at pH 7.0 was 
run for each system (Figs 5D & E and Supplementary Movie 
2).  In the lowest-energy binding poses the pyrophosphate 
group interacted with the ring of lysine residues and the hydro-
phobic tail was encapsulated by the larger hydrophobic section 
of the channel (Supplementary Figs 23 and 24).  For the 
CpHMD simulations, FPP was kept fully deprotonated and the 
protonation states of the Lys-24 residues were allowed to vary.  
For approximately half of the simulation, 5 of the Lys residues 
were protonated, and for the remainder either 6, 3 or 7 lysine 
residues (ranked by decreasing prevalence) were charged (Sup-
plementary Fig 25).  The charged FPP remained in a stable po-
sition throughout the course of the simulations (Supplementary 
Fig 26), with the hepta-Lys ring accommodating the 3 negative 
charges of the pyrophosphate through strong Coulombic inter-
actions.  However, the Lys side chains were mobile (Supple-
mentary Fig 27) and not all interacted with FPP throughout the 
simulation (Supplementary Fig 24); but the protein backbone 
remained stable (Supplementary Fig 28). 
 
 
Figure 5. Binding of bioactive hydrophobic molecules to engi-
neered CC-Hept channels. (A) Saturation binding of TMA-DPH to 
CC-Hept (red), CC-Hept-I24K (blue) and CC-Hept-I24E (purple).  
Conditions: 1.4 – 100 M coiled-coil assembly, 1 M dye, HBS, 
5% v/v DMSO. (B&C) Fluorescence-based competition assays 
with TMA-DPH bound to CC-Hept, CC-Hept-I24K, and CC-Hept-
I24E (colour key as above) being displaced by farnesol (B) or far-
nesol diphosphate (C).  Conditions: 50 M TMA-DPH, 1.4 M 
coiled-coil assembly, HBS, 5% v/v DMSO, 20 ˚C. Concentration 
of ligands varied between 0.1 and 500 M. (D&E) Orthogonal 
views of a pose from the MD simulation of FPP bound to CC-Hept-
I24K. FPP is shown in sticks with the carbon atoms colored ma-
genta; Lys-24 residues are represented by sticks with spheres for 
the titratable protons. 
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CONCLUSION 
  We have demonstrated the ability to sequester lipophilic and 
charged molecules with varying affinities into the central lu-
mens of a series of de novo designed -helical barrel (HB) 
scaffolds including a pentamer, a hexamer and a heptamer.  For 
the first-generation HBs, the lumens are lined exclusively by 
hydrophobic residues.  Consistent with this, all of the barrels 
reversibly bind the environment-sensitive hydrophobic dye di-
phenylhexatriene (DPH) to give signals in both fluorescence 
and CD spectroscopy.  The former provides a reporter in a dis-
placement assay for the binding of non-fluorescent analytes to 
HBs.  The varying internal diameters of the structures, which 
are in the range 5 Å – 7 Å, provide a first-order discriminating 
factor for differential binding of a small panel of lipophilic 
small biomolecules, which includes palmitic acid, retinol, far-
nesol and -carotene.   
  The different binding modes and affinities of the various mol-
ecules to the HBs can be rationalized by the physical proper-
ties of the small molecules, and through molecular modelling 
and dynamics simulations.  In particular, a second discrimina-
tion factor was identified as the internal shape of the channels 
which alternate widened voids separated by narrower sections.  
Although bulky groups can be accommodated within the nar-
rowed sections, binding there is less favorable and transient.  
Linear unbranched chains are however stable in these tight sec-
tions. Consequently, the length of the cavities and the distance 
between narrowed sections may influence the type of small 
molecule that can be sequestrated by the HBs in the future.   
  Secondary binding features can be added to the basic HB 
scaffolds to tailor binding and selection.  Specifically, we have 
incorporated rings of both negatively and positively charged 
side chains within the lumen of the heptamer to allow the selec-
tive binding of cationic and anionic ligands, respectively.  
Whilst by no means a fully comprehensive set of mutations, this 
highlights the versatility and potential of this system for the de-
sign of ligand binding sites.  The HBs and the principles that 
we advance provide a strong basis for the design and construc-
tion of specific de novo receptor proteins for the recognition, 
binding, and release of bioactive small molecules using water-
soluble HBs and HB-based materials, and to develop mem-
brane-spanning transporters and sensors. 
  In respect of applications, naturally occurring and engineered 
HB coiled-coil scaffolds—e.g., COMPcc, GCN4-pAA—bind 
and encapsulate small molecules.27-29, 48  However, the de novo 
designed systems described herein have important differences 
and potential advantages: 1) By changing the lengths and oligo-
mer states of the peptides, the lengths and diameters of the hy-
drophobic channels can be tuned to accommodate specific tar-
get molecules or classes of molecule. 2) As the parent designs 
are thermostable and have low-complexity repeat sequences, 
the de novo HBs tolerate a large number of mutations in their 
lumens, enabling polar and charged side chains to be incorpo-
rated and, in turn, functionalized molecules to be sequestered. 
  The demonstration of designed binding also adds to their 
emerging potential as de novo biocatalysts for specific sub-
strates.9  This variety, modularity and flexibility of the de novo 
HB systems bode well for their application in biotechnology 
and synthetic biology as vehicles for small-molecule recogni-
tion, capture, storage and release and as the active components 
of new biosensor and diagnostics devices. 
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